Evidence map›Paper›PMID 18959790›Full record

ArticleMalaria journal2008

A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking.

Rachel Daniels, Sarah K Volkman, Danny A Milner, Nira Mahesh, Daniel E Neafsey, Daniel J Park, David Rosen, Elaine Angelino, Pardis C Sabeti, Dyann F Wirth and 1 more

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Malaria journal, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 157 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
157citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

157 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Adherence to Mass Drug Administration with Dihydroartemisinin-Piperaquine andThe American journal of tropical medicine and hygiene · 2020
    Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. BMJ open · 2024
    Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

97 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rachel DanielsBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. rdaniels@broad.mit.edu
Sarah K Volkman
Danny A Milner
Nira Mahesh
Daniel E Neafsey
Daniel J Park
David Rosen
Elaine Angelino
Pardis C Sabeti
Dyann F Wirth
Roger C Wiegand

Funding

Genetic Diversity of Plasmodium falciparum and Severe Malaria in AfricaK23AI072033 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MILNER, DANNY ARNOLD · 2007 to 2011
$675k
NIAID NIH HHS K23 AI072033NIAID NIH HHS K23AI072033-01Wellcome Trust
6 · The paper itself

Abstract

backgroundSingle nucleotide polymorphism (SNP) genotyping provides the means to develop a practical, rapid, inexpensive assay that will uniquely identify any Plasmodium falciparum parasite using a small amount of DNA. Such an assay could be used to distinguish recrudescence from re-infection in drug trials, to monitor the frequency and distribution of specific parasites in a patient population undergoing drug treatment or vaccine challenge, or for tracking samples and determining purity of isolates in the laboratory during culture adaptation and sub-cloning, as well as routine passage.

methodsA panel of twenty-four SNP markers has been identified that exhibit a high minor allele frequency (average MAF > 35%), for which robust TaqMan genotyping assays were constructed. All SNPs were identified through whole genome sequencing and MAF was estimated through Affymetrix array-based genotyping of a worldwide collection of parasites. These assays create a "molecular barcode" to uniquely identify a parasite genome.

resultsUsing 24 such markers no two parasites known to be of independent origin have yet been found to have the same allele signature. The TaqMan genotyping assays can be performed on a variety of samples including cultured parasites, frozen whole blood, or whole blood spotted onto filter paper with a success rate > 99%. Less than 5 ng of parasite DNA is needed to complete a panel of 24 markers. The ability of this SNP panel to detect and identify parasites was compared to the standard molecular methods, MSP-1 and MSP-2 typing.

conclusionThis work provides a facile field-deployable genotyping tool that can be used without special skills with standard lab equipment, and at reasonable cost that will unambiguously identify and track P. falciparum parasites both from patient samples and in the laboratory.

Indexed as

Microarray AnalysisPolymorphism, Single NucleotideAnimalsDNA FingerprintingDNA, ProtozoanGenotypePlasmodium falciparumDNA, Protozoan

Identifiers

PMID18959790
PMCPMC2584654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.